# A Study to Learn About How Elinzanetant Works and How Safe it is in Women Having Sleep Disturbances Associated With Menopause

> **NCT06112756** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 110 (actual)

## Conditions studied

- Sleep Disturbances Associated With Menopause

## Interventions

- **DRUG:** Elinzanetant
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06112756
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-08
- **Primary completion:** 2024-08-22
- **Final completion:** 2024-11-07
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2025-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06112756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06112756, "A Study to Learn About How Elinzanetant Works and How Safe it is in Women Having Sleep Disturbances Associated With Menopause". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06112756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*